Sign Up Today and Learn More About Careviso Stock
Invest in or calculate the value of your shares in Careviso or other pre-IPO companies through EquityZen's platform.
Careviso Stock (CARI)
Careviso is a technology healthcare company helping to simplify and streamline patient access for molecular diagnostics.
About Careviso Stock
Founded
2017
Headquarters
Falls Church, VA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Careviso Press Mentions
Stay in the know about the latest news on Careviso
careviso Introduces "Prior Authorization on File" New Product Feature within seeQer and Delivers Record 2026 Reverification Performance
prnewswire • Mar 06, 2026
careviso Introduces "Prior Authorization on File" New Product Feature within seeQer and Delivers Record 2026 Reverification Performance
morningstar • Mar 06, 2026
careviso Launches Coordination of Benefits Feature to Enhance Accuracy in Patient Eligibility and Cost Estimates
prnewswire • Oct 23, 2025
careviso Launches Coordination of Benefits Feature to Enhance Accuracy in Patient Eligibility and Cost Estimates
morningstar • Oct 23, 2025
careviso Participates in HL7® Da Vinci Project Connectathon Track to Showcase Healthcare No Surprises Act Leadership with seeQer Price Transparency Tool
prnewswire • Oct 06, 2025
Careviso Management
Leadership team at Careviso
Co-Founder & Chief Business Officer
Perry Dimas
Chief Operating and Financial Officer
John Pavlovich
Join now and verify your accreditation status to gain access to:
- Careviso Current Valuation
- Careviso Stock Price
- Careviso Management
- Available deals in Careviso and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Careviso Cap Table and Funding History by Share Class and Liquidity Preferences
- Careviso Revenue and Financials
- Careviso Highlights
- Careviso Business Model
- Careviso Risk Factors
- Careviso Research Report from SACRA Research
Trading Careviso Stock
How to invest in Careviso stock?
Accredited investors can buy pre-IPO stock in companies like Careviso through EquityZen funds. These investments are made available by existing Careviso shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Careviso stock?
Shareholders can sell their Careviso stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
